The serum levels of AFP in HCC patients, CHB-related cirrhosis patients and non-cirrhosis patients were 148.62 ± 303.99, 15.16 ± 7.06 and 8.27 ± 6.03, respectively (P < 0.001). Here, AFP is linked to hepatocellular carcinoma.